2008 AVAC Report The Search Must Continue
The 2008 AVAC Report,
The Search Must Continue,
provides a comprehensive review of recent
developments in AIDS vaccine research. It
explores the issues that have been raised in
the wake of the failure of Merck's vaccine
candidate and provides context for the events
and major changes of the last year in HIV
prevention research.
In the report, AVAC
argues that continuing to move forward with
AIDS vaccine research and testing is imperative
and lays out recommendations for the AIDS
vaccine and HIV prevention field. It also looks
at the comparative advantages of major players,
including the U.S. National Institutes of
Health and the International AIDS Vaccine
Initiative, and analyzes the current
environment for decision-making about future
clinical trials.
The Search Must
Continue - click to download the
full PDF
The Story that Must be
Told: A letter from the Executive
Director
AVAC's Top 10 Recommendations
for 2008 and Beyond
AVAC Report 2008 At a
Glance
Status Report - An Update on
Last Year's Recommendations
Chapter 1: The Whole Wide
World: Global priorities around HIV prevention
research
Figure 1: HIV Prevention
Research : A Comprehensive Timeline of
Anticipated Results from Efficacy
Trials
Table 1: Ongoing and Planned
PrEP Trials (April 2008)
Figure 2: Ongoing Trials of New
Prevention Options Worldwide (April
2008)
Chapter 2: What 's ( Y )our
Position? Where we stand in the post-STEP
era
Figure 3: The Era of Flat
Funding: NIH and NIAID AIDS Research Funding FY
1989-2009
Figure 4: Losing Power: The
Impact of Inflation on the Flat NIH
Budget
Table 2: Ongoing Trials of
Preventive HIV/AIDs Vaccine Worldwide (April
2008)
Figure 5: Why An AIDS Vaccine
is Possible
Chapter 3: What We Know for
Sure: Lessons to be learned from the STEP
study
Figure 6: Starting the
"Post-STEP" Era: A Timeline
Figure 7: All in This Together:
Layers of the Aids Vaccine Community
Figure 8: Projected HIV
Prevalence By Age: US and African-American
MSM
Figure 9: HIV Prevalence by Age
Among US and African-America MSM: Current
Estimates
Figure 10: Data on Rates of
Report Risk Behavior Among Male Volunteers in
the STEP Trial
Table 3: Proportion of STI
Prevention Expenditures Targeted at MSM in
Asia
Chapter 4: Moving Forward,
Looking Back: Studying the IAVI model
Figure 11: Annual Public and
Philanthropic Investments in Preventive HIV
Vaccine R&D from 2000 to 2006
Figure 12: Financing the
Search
Figure 13: Global Distribution
of Vaccine Trial Sites
Science Snapshot: Quick Takes
on Next Steps in the Search for an AIDS
Vaccine